ArticleMolecular therapy. Methods & clinical development2021

Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia.

Scott Raskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.